A Phase I/II Study of ASTX660 in Patients With Relapsed or Refractory T-cell Lymphoma

Clinical trial NCT04362007 · TERMINATED

Trial details

NCT number: NCT04362007
Sponsor: Otsuka Pharmaceutical Co., Ltd.
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Relapsed or Refractory Peripheral T-cell Lymphoma(PTCL),Cutaneous T-cell Lymphoma(CTCL),Adult T-cell Leukemia/Lymphoma(ATLL)

Start date: 2020-07-14
Primary completion: 2024-11-30
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.